• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Labor Induction with 50 μg Vaginal Misoprostol: Can We Reduce Induction-Delivery Intervals Safely?使用50微克阴道米索前列醇引产:我们能否安全缩短引产至分娩间隔时间?
J Obstet Gynaecol India. 2014 Aug;64(4):270-3. doi: 10.1007/s13224-014-0521-8. Epub 2014 Apr 12.
2
Misoprostol: an effective agent for cervical ripening and labor induction.米索前列醇:一种有效的宫颈成熟和引产药物。
Am J Obstet Gynecol. 1995 Jun;172(6):1811-6. doi: 10.1016/0002-9378(95)91416-1.
3
Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial.足月引产时阴道用米索前列醇与地诺前列酮阴道栓剂的疗效及安全性比较:一项随机试验
Arch Gynecol Obstet. 2009 Jul;280(1):19-24. doi: 10.1007/s00404-008-0843-9. Epub 2008 Nov 26.
4
A comparison of misoprostol and prostaglandin E2 gel for preinduction cervical ripening and labor induction.米索前列醇与前列腺素E2凝胶用于引产术前宫颈成熟和引产的比较。
Am J Obstet Gynecol. 1995 Jun;172(6):1804-10. doi: 10.1016/0002-9378(95)91415-3.
5
Efficacy and safety of intravaginal misoprostol versus intracervical dinoprostone for labor induction at term: a systematic review and meta-analysis.足月引产时阴道内使用米索前列醇与宫颈内使用地诺前列酮的疗效及安全性:一项系统评价和荟萃分析。
J Obstet Gynaecol Res. 2014 Apr;40(4):897-906. doi: 10.1111/jog.12333.
6
Six hourly vaginal misoprostol versus intracervical dinoprostone for cervical ripening and labor induction.每六小时阴道用米索前列醇与宫颈内用地诺前列酮用于促宫颈成熟及引产的比较
J Obstet Gynaecol Res. 2003 Jun;29(3):147-51. doi: 10.1046/j.1341-8076.2003.00091.x.
7
A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction.米索前列醇间断阴道给药与地诺前列酮持续给药用于促宫颈成熟和引产的比较。
Am J Obstet Gynecol. 1997 Sep;177(3):612-8. doi: 10.1016/s0002-9378(97)70154-6.
8
Misoprostol for induction of labour: a systematic review.米索前列醇用于引产:一项系统评价。
Br J Obstet Gynaecol. 1999 Aug;106(8):798-803. doi: 10.1111/j.1471-0528.1999.tb08400.x.
9
Safety of misoprostol vs dinoprostone for induction of labor: A systematic review and meta-analysis.米索前列醇与地诺前列酮用于引产的安全性:一项系统评价与荟萃分析。
Eur J Obstet Gynecol Reprod Biol. 2023 Oct;289:108-128. doi: 10.1016/j.ejogrb.2023.08.382. Epub 2023 Aug 28.
10
Randomized study of vaginal misoprostol (PGE(1)) and dinoprostone gel (PGE(2)) for induction of labor at term.阴道用米索前列醇(PGE₁)与地诺前列酮凝胶(PGE₂)足月引产的随机研究。
Ultrasound Obstet Gynecol. 2001 Dec;18(6):629-35. doi: 10.1046/j.0960-7692.2001.00595.x.

本文引用的文献

1
Induction of labor.引产
Obstet Gynecol Clin North Am. 2005 Jun;32(2):181-200, viii. doi: 10.1016/j.ogc.2004.12.004.
2
Randomized comparison between intravaginal misoprostol and dinoprostone for cervical ripening and induction of labor.阴道内使用米索前列醇与地诺前列酮用于促宫颈成熟及引产的随机对照研究
Am J Obstet Gynecol. 1999 Sep;181(3):626-9. doi: 10.1016/s0002-9378(99)70503-x.
3
Misoprostol for induction of labour at term: a more effective agent than dinoprostone vaginal gel.米索前列醇用于足月引产:一种比地诺前列酮阴道凝胶更有效的药物。
Br J Obstet Gynaecol. 1999 Aug;106(8):793-7. doi: 10.1111/j.1471-0528.1999.tb08399.x.
4
Misoprostol is more efficacious for labor induction than prostaglandin E2, but is it associated with more risk?米索前列醇用于引产比前列腺素E2更有效,但它的风险更高吗?
Am J Obstet Gynecol. 1999 Jun;180(6 Pt 1):1543-50. doi: 10.1016/s0002-9378(99)70050-5.
5
Labor induction with prostaglandin E1 misoprostol compared with dinoprostone vaginal insert: a randomized trial.米索前列醇(前列腺素E1)与地诺前列酮阴道栓剂用于引产的比较:一项随机试验
Obstet Gynecol. 1998 Mar;91(3):401-5. doi: 10.1016/s0029-7844(97)00673-x.
6
A randomized clinical trial comparing misoprostol with prostaglandin E2 gel for preinduction cervical ripening.一项比较米索前列醇与前列腺素E2凝胶用于引产术前宫颈成熟的随机临床试验。
Am J Obstet Gynecol. 1997 Nov;177(5):1067-70. doi: 10.1016/s0002-9378(97)70016-4.
7
A double-blind comparison of the safety and efficacy of intravaginal misoprostol and prostaglandin E2 to induce labor.阴道内使用米索前列醇和前列腺素E2引产安全性及有效性的双盲比较。
Am J Obstet Gynecol. 1997 Nov;177(5):1018-23. doi: 10.1016/s0002-9378(97)70006-1.
8
A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction.米索前列醇间断阴道给药与地诺前列酮持续给药用于促宫颈成熟和引产的比较。
Am J Obstet Gynecol. 1997 Sep;177(3):612-8. doi: 10.1016/s0002-9378(97)70154-6.
9
Misoprostol for cervical ripening and labor induction: a meta-analysis.米索前列醇用于宫颈成熟和引产:一项荟萃分析。
Obstet Gynecol. 1997 Apr;89(4):633-42. doi: 10.1016/S0029-7844(96)00374-2.
10
A randomized comparison between misoprostol and dinoprostone for cervical ripening and labor induction in patients with unfavorable cervices.米索前列醇与地诺前列酮用于宫颈条件不佳患者促宫颈成熟及引产的随机对照研究
Obstet Gynecol. 1997 Apr;89(4):581-5. doi: 10.1016/S0029-7844(97)00015-X.

使用50微克阴道米索前列醇引产:我们能否安全缩短引产至分娩间隔时间?

Labor Induction with 50 μg Vaginal Misoprostol: Can We Reduce Induction-Delivery Intervals Safely?

作者信息

Sareen Sweta, Chawla Indu, Singh Pushpa

机构信息

Department of Obstetrics & Gynecology, Dr. RML Hospital & PGIMER, New Delhi, 110001 India ; 3/18, 2nd Floor, Old Rajender Nagar, New Delhi, 110060 India.

Department of Obstetrics & Gynecology, Dr. RML Hospital & PGIMER, New Delhi, 110001 India.

出版信息

J Obstet Gynaecol India. 2014 Aug;64(4):270-3. doi: 10.1007/s13224-014-0521-8. Epub 2014 Apr 12.

DOI:10.1007/s13224-014-0521-8
PMID:25136173
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4126944/
Abstract

OBJECTIVE

To compare the efficacy and safety profile of two methods of labor induction i.e., intracervical dinoprostone gel (0.5 mg 8 h) and misoprostol (50 μg 4 h) for induction of labor in women with a poor Bishop's score.

DESIGN

Observational study.

STUDY PERIOD

January 1st, 2009 to December 31st, 2010.

POPULATION

A total of 329 women with unfavorable cervices induced at or near term.

METHODS

Two cervical ripening agent study arms were used: dinoprostone gel (193 women) and misoprostol (137 women).

MAIN OUTCOME MEASURES

Induction to delivery interval, cesarean section, incidence of meconium stained liquor, FHR pattern, incidence of uterine hyperstimulation, and neonatal outcomes.

RESULTS

The induction to delivery interval was significantly shorter in the misoprostol group as compared to the dinoprostone group (p < 0.001). There was no difference in cesarean section rates between the two groups (dinoprostone gel 43 %; misoprostol 33 %; p = 0.144). The incidence of non-reassuring fetal heart rate pattern, meconium stained liquor, and uterine hyperstimulation were equivalent in both the groups (p = 0.529; 0.733; and 0.321, respectively). The neonatal outcomes in both the groups were comparable in terms of Apgar scores at birth (p = 0.160) and NICU admissions (p = 0.951).

CONCLUSIONS

Labor induction in women with unfavorable cervices results in high caesarean section rates. However, the use of misoprostol significantly reduces the induction to delivery interval, without adversely affecting the caesarean section rates and neonatal outcomes. Hence it may become a cost-effective alternative to dinoprostone gel in resource-poor settings like India.

摘要

目的

比较两种引产方法的疗效和安全性,即宫颈内使用地诺前列酮凝胶(0.5毫克,每8小时一次)和米索前列醇(50微克,每4小时一次),用于Bishop评分低的女性引产。

设计

观察性研究。

研究期间

2009年1月1日至2010年12月31日。

研究对象

共329名宫颈条件不佳的足月或近足月引产女性。

方法

采用两种宫颈成熟剂研究组:地诺前列酮凝胶(193名女性)和米索前列醇(137名女性)。

主要观察指标

引产至分娩间隔、剖宫产、羊水粪染发生率、胎儿心率模式、子宫过度刺激发生率及新生儿结局。

结果

与地诺前列酮组相比,米索前列醇组引产至分娩间隔显著缩短(p<0.001)。两组剖宫产率无差异(地诺前列酮凝胶43%;米索前列醇33%;p=0.144)。两组胎儿心率异常模式、羊水粪染及子宫过度刺激发生率相当(分别为p=0.529、0.733和0.321)。两组新生儿结局在出生时阿氏评分(p=0.160)和入住新生儿重症监护病房情况(p=0.951)方面具有可比性。

结论

宫颈条件不佳的女性引产导致剖宫产率较高。然而,使用米索前列醇可显著缩短引产至分娩间隔,且不影响剖宫产率和新生儿结局。因此,在印度等资源匮乏地区,它可能成为地诺前列酮凝胶具有成本效益的替代方案。